1 On subset analysis of
349 AYA patients with tumors of the stomach and small intest
2 enrollment and time to treatment among 1,
358 AYA patients with cancer (age 15 to 39 years) identified
3 This study included
392 AYA and 5373 OA patients diagnosed with GISTs (207 [52.8
4 This retrospective cohort study of
392 AYA patients and 5373 older adult (OA) patients in the S
5 OPE) study, a population-based cohort of
523 AYA patients with cancer, ages 15 to 39 years at diagnos
6 y data and electronic health records for
663 AYA patients with either stage I to III cancer and evide
7 s is a retrospective case-only study of
8860 AYA breast cancer cases diagnosed from 1997 to 2006 usin
8 On subset analysis of
91 AYA patients with metastatic disease, operative manageme
9 lts, the care of adolescent and young
adult (
AYA) patients with acute lymphoblastic leukemia (ALL) po
10 quality care for adolescent and young
adult (
AYA) patients with cancer and survivors requires an unde
11 Because adolescent and young
adult (
AYA) patients with cancer have experienced variable impr
12 cer diagnosis in adolescent and young
adult (
AYA) patients with cancer.
13 ls who work with adolescent and young
adult (
AYA) patients with cancer.
14 y was to compare adolescent and young
adult (
AYA) pediatric cancer survivors and peers without a hist
15 outcomes of the adolescent and young
adult (
AYA) population with gastrointestinal stromal tumors (GI
16 t groups for the adolescent and young
adult (
AYA) population with HL.
17 is important to adolescent and young
adult (
AYA) survivors of cancer.
18 Adolescents and young
adults (
AYA) with cancer have been designated as a vulnerable po
19 and OA (>/=40 years old) patients and
among AYA patients stratified by operative management.
20 rtise in the following three critical
areas:
AYA-specific medical knowledge; care delivery specific t
21 CONCLUSION AYA cancer survivors did not differ from peers in psycho
22 Results Recently
diagnosed AYA patients with cancer had significantly worse physica
23 the 12- to 24-month period after
diagnosis,
AYA patients may benefit from supportive care interventi
24 dult Health Outcomes and Patient
Experience (
AYA HOPE) study, a population-based cohort of 523 AYA pa
25 r Registry (CCR) was used to identify
female AYA cancer survivors diagnosed from January 2000 to Dece
26 inform the reproductive counseling of
female AYA cancer survivors.
27 ment of health care professionals caring
for AYA patients with cancer.
28 Five-year survival rates are lowest
for AYA women, and only a few studies have examined the impa
29 PCS but not MCS scores were worse
for AYA patients diagnosed with cancers with poorer prognose
30 , non-conductive HCN4-channel subunit (
hHCN4-
AYA).
31 the prognostic value of TERT alterations
in AYA melanoma, we investigated the association of TERT pr
32 Breast cancer
in AYA women has a worse prognosis than in older women.
33 nt is associated with improved OS and GSS
in AYA patients, including those with metastatic disease.
34 ulation and may predict clinical outcomes
in AYA melanoma.
35 ted with low clinical trial participation
in AYA patients with cancer.
36 th new insights into disease pathogenesis
in AYA ALL and the availability of disease-specific kinase
37 d other socioeconomic factors on survival
in AYA women.
38 To identify current trends
in AYA care, we examined patterns of clinical trial partici
39 ients diagnosed with GISTs (207 [52.8%]
male AYA patients, 2767 [51.5%] male OA patients, 277 [70.7%]
40 PATIENTS AND
METHODS AYA cancer survivors (n = 167) and controls (n = 170), r
41 Compared with the OA patients,
more AYA patients had small-intestine GISTs (139 [35.5%] vs 1
42 Most AYA patients received at least 1 form of medically inten
43 Although
most AYA patients with cancer return to work after cancer, tr
44 Multivariable analysis
of AYA patients found that nonoperative management was asso
45 y, pharmacology, and psychosocial aspects
of AYA patients with ALL, highlighting our current approach
46 derstood about the unique disease biology
of AYA ALL, targeted therapeutic approaches may offer promi
47 15, compared the baseline characteristics
of AYA (13-39 years old) and OA (>/=40 years old) patients
48 To describe a large cohort
of AYA patients with GISTs and investigate the effect of su
49 nd competency in application and delivery
of AYA-specific practical knowledge.
50 Yet efforts
of AYA patients with cancer and survivors to mature are oft
51 tudy was conducted among a diverse sample
of AYA patients with cancer ages 15 to 39 years.
52 racteristics in a population-based sample
of AYA patients with cancer.
53 Although the survival
of AYA patients is inferior to younger children, growing ev
54 A total of 5,673 2-year survivors
of AYA cancer and 57,617 comparison patients were included,
55 Survivors
of AYA cancer are at increased risk for developing CVD.
56 retrospective cohort of 2-year survivors
of AYA cancer who were diagnosed between the ages of 15 to
57 development of prognostic assays to
stratify AYA melanoma patients according to clinical risk.
58 adolescent and young adult cancer
survivors (
AYA [diagnosed at ages 15-39 years]) with those of women
59 As), but little is known about the care
that AYA patients with cancer receive at the end of life (EOL
60 This study found
that AYA patients are more likely to undergo surgical managem
61 ger children, growing evidence suggests
that AYA patients have improved outcomes, with disease-free s
62 number of issues uniquely experienced by
the AYA population that are critical for health care profess
63 reproductive potential are critical for
the AYA population at the time of diagnosis.
64 f the unique distribution of diseases in
the AYA population with cancer and further understanding of
65 ncers manifest themselves differently in
the AYA population, both in terms of biology and treatment r
66 nt, these regimens are well tolerated in
the AYA population.
67 ocols significantly improves outcomes in
the AYA population.
68 y component of successful treatment of
these AYA patients.
69 Overall, 2598 births
to AYA cancer survivors (mean [SD] maternal age, 31 [5] yea
70 Births
to AYA cancer survivors had a significantly increased preva
71 Live births
to AYA cancer survivors may have an increased risk of prete
72 014 to identify postdiagnosis live births
to AYA survivors (n = 2598).
73 At the 24-month follow-
up,
AYA patients still had significantly lower PCS scores (4
74 [51.5%] male OA patients, 277 [70.7%]
white AYA patients, and 3661 [68.1%] white OA patients).
75 rimary oncologist, address these issues
with AYA patients.
76 for health care professionals working
within AYA oncology (AYAO) to understand.